Our study reveals that TIMP1 plays a central role in modulating the CRC immune microenvironment by promoting the infiltration of diverse macrophage subpopulations and neutrophils and collaborates with immune checkpoints to regulate patients’ immune responses. The gene discussed is TIMP1; the disease is colorectal carcinoma.